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ABSTRAK 
Kajian status paras vitamin D dan penentuan tahap vitamin D yang optimum 
berdasarkan penanda aktiviti tulang di Kota Bharu, Kelantan 
Latar Belakang: Masih tiada tahap optin1un1 atau mubang yang jelas bagi 1nenentukan 
sama ada terdapat bekalan yang mencukupi untuk vitamin D dalam badan untuk 
kesihatan tulang. Oleh itu, kajian kami adalah untuk menentukan tahap optimum 
vitamin D untuk penyelenggaraan tulang yang sihat berdasarkan proses pembentukan 
semula tulang. 
Kaedah: Ini adalah satu kaj ian keratan rentas lintang yang melibatkan penduduk 
dewasa yang sihat di Kota Bharu, Malaysia, berumur 18-50 tahun. Kami mengukur 
serum vitamin D 25 (OH) D, serum horrnon paratiroid (PTH), serum C-terrninal 
telopeptide of type 1 collagen (C~TX) dan jumlah Procollagen I Intact N-Terrninal 
(P 1 NP) di kalangan 120 orang dewasa yang sihat dari 6 sub daerah yang telah dipilih 
secara persampelan berperingkat ( 64 lelaki, 56 perempuan ). 
Keputusan: Purata vitamin D dalam kajian ini adalah 23.50 nmol/L dan terdapat 
perbezaan yang signifikan pada tahap vitamin D antarajantina (26.81 ± 8.3 nmol/L)bagi 
lelaki dan(l9.72 ± 7.68 nmol/L) bagi perempuan. Lebih daripada 50% daripada subjek 
perempuan mempunyai vitamin D kurang daripada 20 nmol/L, manakala hanya 20.3o/o 
daripada subjek lelaki mempunyai vitamin D di bawah 20 nmoVL. Berdasarkan loess 
plot, serum CTX tidak menunjukkan kenaikan di peringkat vitamin D pada tahap 
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35nmol!L. Jumlah Serum PlNP dilihat sebagai mendatar apabila vitamin D adalah 
sekitar 20 nmol/L. Begitu juga, pada 20 nmol/L terdapat penurunan tahap PTH. 
Kesimpulan: Purata vitamin D di kalangan penduduk dewasa sihat di Kota Bharu 
adalah 23.50 nmol/L. Seterusnya, berdasarkanpenanda aktiviti tulang , kami membuat 
kesimpulan bahawa tahap vitamin D antara 20 nmol/L hingga 35 nmol!L dianggap 
mencukupi untuk mengekalkan tulang yang sihat. 
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ABSTRACT 
Study on vitamin D status and determination of optimum vitamin D level based on 
bone turnover markers in Kota Bharu, Kelantan 
Background: There is no optilnmn level or threshold that has been clearly established 
to define whether there is adequate store of vitamin D in the body for general bone 
health. Therefore, our study is to determine the optimum level of vitamin D for 
maintenance of healthy skeleton based on bone remodelling process. 
Methods: This was a cross sectional study involving healthy adult population in Kota 
Bharu, Malaysia, aged 18-50 years. We measured serwn 25(0H)D, serum parathyroid 
hormone (PTH), serum C-terminal telopeptide of type 1 collagen ( CTX) and 
Procollagen 1 Intact N-Terminal (P1NP) in 120 healthy adult from 6 sub districts that 
had been selected by multi stage sampling ( 64 males, 56 females). 
Results: The mean of vitamin Din this study was 23.50 (±8.74) nmol/L and there was 
significant difference of vitamin D betvveen gender (26.81±8.3 nmol/L and 19.72±7.68 
nmol/L males and females respectively), p value < 0.001. More than 50% of female 
subjects had vitamin D less than 20 nmol/L, while only 20.3% of male subjects had 
vitamin D below 20 nmol/L. Based on LOESS plot, the bone turnover markers showed 
plateau result at vitamin D level of 3 5 nmoi!L for CTX and 20 nmoi/L for p 1 NP. Then, 
at vitamin D level of 20 nmol/L there is a step decrease of PTH level. 
Conclusion: The mean of vitamin D among general healthy population in Kota Bharu 
was 23.50nmoi/L. Based on inspection of LOESS plot for CTX, PlNP and PTH versus 
vitamin D level, we concluded that vitamin D level between 20 nmol/L to 35 nmol/L is 





Vitamin D deficiency is a global public health concern for most of the countries 
nowadays (Langlois et al., 2010). New discoveries have proved that vitamin D 
deficiency is also related to higher risk of cardiovascular disease, diabetes mellitus, 
cancer and auto immune disease, apart from its key role in bone metabolism  (Hullett et 
al., 1998; Nagpal et al., 2005; Martini and Wood, 2008). 
Vitamin D, which is also called as sunshine vitamin is not a vitamin or nutrient by itself. 
In 1969, after the discovery of vitamin D receptor, it is recognized that the term vitamin 
D is inappropriate. Vitamin D is better to be defined as a complex endocrine system 
(Norman, 2008). The reasons are that,  because of  i) it can be endogenously synthesize, 
ii) presence of specific receptor , iii)  actions in many organs and tissues, iv) induction 
of specific biologic response after interaction with its receptor. The actions of vitamin D 
are not limited to the target organs that are required for mineral ion homeostasis but its 
receptor is present in many more cells type and can elicit specific biological actions on 
such tissues (Gallieni et al., 2009).  
 
1.1 VITAMIN D – SOURCE AND PRODUCTION 
Vitamin D has two forms, cholecalciferol (vitamin D3) and ergocalciferol (vitamin D2). 
Vitamin D3 derives from dietary sources (salmon, mackerel, tuna, cod liver oil) but it 
can also be produced in the skin from  7-dehydrocholesterol (7-DHC) or provitamin D 
(Holick, 2007). During exposure to light, 7-DHC absorbs solar radiation which 
transforms it to previtamin D3. After few hours, it undergoes isomerization to 
cholecalciferol. It is then transported from skin to circulation by binding to vitamin D 
binding protein. Factors that affect the vitamin D production by the skin include 
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latitude, time of day, season of the year, skin pigmentation, sunscreen usage, type of 
clothing and also age, as the old people have reduced 7-DHC in their skin (Marrone et 
al., 2012).  
Ergocalciferol (vitamin D2) is a synthetic molecule produced from ergosterol which is a 
component of fungal cell membrane. This vitamin D2 therefore can be found in fortified 
foods like milk, cheese, cereals and yogurt especially in the Western countries. This 
vitamin D2 also can be administered as supplement either orally or parenterally. Table 
1.1 shows list of food with vitamin D concentrations. 
 
Table 1.1 : Food sources of vitamin D     IU: international unit; DV: daily value 
Source : Adopted from USDA (United State Department of Agriculture) 
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1.2 VITAMIN D -  METABOLISM 
Vitamin D in circulation is bound to vitamin D binding protein and transported to the 
liver where it is converted to 25-hydroxy vitamin D [25(OH) D]. This is the major 
circulating form of vitamin D that is used to measure vitamin D status in a person 
(Jones, 2006). It is biologically inactive and must be converted to its active form, 1,25-
dihydroxy vitamin D [1,25(OH)2 D] or also called calcitriol. This step occurred in the 
kidney by the enzyme 25-hydroxyvitamin D-1 α hydroxylase.  
The renal production of calcitriol is tightly controlled by many factors like serum 
calcium, phosphorus and parathyroid hormone (PTH) level (Prié et al., 2005). This 
active form of vitamin D regulates the synthesis and secretion of the PTH and also 
increases intestinal calcium and phosphorus absorption together with renal calcium 
reabsorption (Tonelli et al., 2005). Fibroblast growth factor 23 (FGF 23), which is 
released from the bone suppresses calcitriol synthesis as a negative feedback 
mechanism (Murer et al., 2000).  
Calcitriol induces its own destruction by rapidly inducing the 25-hydroxyvitamin D-24-
hydroxylase, which leads to the multistep catabolism of both 25(OH)D and 1,25(OH)2D 
into biologically inactive, water-soluble metabolites including calcitroic acid and 







Figure 1.1: The photoproduction and metabolism of vitamin D and the various 
biologic effects of 1,25(OH)2 D on calcium, phosphorus, and bone metabolism. 







1.3 FUNCTION OF VITAMIN D  
1.3.1 CLASSICAL ROLE 
This vitamin D endocrine system is a foundation to maintain the extracellular calcium 
level within narrow limits for normal cellular function and skeletal integrity (Tsiaras 
and Weinstock, 2011). The target organs which are under influence of vitamin D are the 
intestine, bone, renal and parathyroid gland. 
Intestine : Vitamin D enhances intestinal absorption of calcium and phosphorus by 
promoting active cellular calcium uptake  and transport mechanism. It also amplifies 
active phosphate transport through stimulation of the expression of the sodium-
phosphate cotransporter and changes in the composition of plasma membrane that 
augment phosphate uptake. Without vitamin D, about 10 to 15% of calcium and 60% 
phosphorus is absorbed. With the presence of vitamin D, the efficiency is elevated up to 
30 to 40% for calcium absorption and phosphorus up to 80% (Lorenz-Depiereux et al., 
2006) 
Renal : Calcitriol increases renal calcium and phosphate reabsorption. Apart from that, 
it strictly controls its own homeostasis through simultaneous suppression of 1α-
hydroxylase and stimulation of 24-hydroxylase in the kidney (Gallieni et al., 2009).   
Bone : The vitamin D hormonal system plays an important role in allowing individuals 
to mobilize calcium from bone when it is absent from diet. The vitamin D hormonal 
system appears necessary for PTH-induced osteoclast production (Dusso et al., 2005). 
Osteoblasts express a surface ligand, named as receptor activator of nuclear factor -κB 
ligand (RANKL), which can bind receptor activator of nuclear factor –κB (Tonelli et 
al.) (Tonelli et al.). The binding of RANKL to RANK generates a signalling cascade 
that results in differentiation and maturation of osteoclasts. Calcitriol, PTH and 
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prostaglandins stimulate RANKL expression, which causes an increase in 
osteoclastogenesis and osteoclast activity thus increased in bone resorption (Holick, 
2007). Apart from that, vitamin D is also pivotal for development and maintenance of a 
mineralized skeleton along with adequate calcium level. It also serves a critical function 
for the normal bone turnover. In vitamin D deficiency, the bone turnover process 
becomes imbalance between the bone formation and bone resorption activity. 
Parathyroid : Parathyroid cells expressed a great number of vitamin D receptor which 
respond to calcitriol binding by reducing the PTH synthesis and secretion. Vitamin D 
deficiency thus, will results in PTH hyperplasia, thereby increasing PTH synthesis and 
secretion. The PTH enhances the tubular reabsorption of calcium and stimulate the 
kidneys to synthesis calcitriol (Tonelli et al., 2005). Apart from that, PTH also 
stimulates osteoblast, which augment the transformation of preosteoclast into mature 
osteoclast for bone resorption (Block et al., 1998).  
1.3.2 NON CLASSICAL ROLE 
Apart from its classical function, this vitamin also has shown many other extra skeletal 
health benefits. Vitamin D receptor has been found in B and T lymphocytes in the 
immune system, hair follicle, muscle, adipose tissue, pancreatic beta-cell, bone marrow, 
and cancer cells (Holick, 2004).  
An example of an autoimmune disease that can be modulated by the vitamin D system 
is type 1 diabetes mellitus. A study by Zella and Deluca (2003) have found that, 1) in 
rats, vitamin D deficiency caused an increase in incidence of diabetes; 2) large doses of 
calcitriol could suppress type 1 diabetes mellitus completely, preventing the destruction 
of islet cells. Similar results were gathered with models of other autoimmune diseases, 
such as systemic lupus, inflammatory bowel disease, and rheumatoid arthritis (Nagpal et 
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al., 2005). In parallel to that, the use of vitamin D receptor activators could be helpful in 
preventing transplant rejection (Hullett et al., 1998).  
Other studies found that several cancer cell lines proved to be respondent to calcitriol 
and other vitamin D analogs, such as prostate, breast, colon cancer cells as well as 
leukemic cells and squamous cell carcinoma (Nagpal et al., 2005).  
Cardiovascular effect is another important area of interest in vitamin D research, as 
epidemiological studies have shown an inverse correlation between UV light exposure 
and in general, an association between vitamin D status and blood pressure (Martini and 
Wood, 2008). 
 
1.4 VITAMIN D AND BONE HEALTH 
Vitamin D is paramount in the development and sustainment of a healthy skeleton from 
the intrauterine life until the old ages. Vitamin D deficiency in pregnant mothers was 
associated with a significant reduction in bone mineral acquisition in infants that persist 
after 9 years after birth (Mulligan et al., 2010). In growing children, lack of vitamin D 
causes chondrocyte disorganization and hypertrophy at the mineralization front and 
defects in bone mineralization causing rickets. This disease is characterized by growth 
retardation, enlargement of the epiphyses of the long bones, deformities of the legs, 
bending of the spine, knobby projections of the ribcage, and weak and toneless muscles 
(Rajakumar, 2003). 
In adults, vitamin D deficiency and hyperparathyroidism will result in low serum 
calcium and phosphorus predisposing them to osteomalacia, a defective mineralization 
of collagen matrix. This eventually will cause reduction of structural support and 
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associated with higher risk for fracture (Bergwitz et al., 2006). Secondary 
hyperparathyroidism as a consequence of vitamin D deficiency is associated with 
osteoclastogenesis and an exaggerate bone resorption. Increased bone resorption 
precipitates and exacerbates osteopenia and osteoporosis in adults.  
Vitamin D promotes bone health by keeping the PTH in healthy levels, boosting 
osteoblastic activity and fostering bone mineralization as well as reducing risk of falls 
thereby reducing risk of fracture. 
 
Figure 1.2: Schematic presentation of pathways from vitamin D deficiency and 
secondary hyperparathyroidism to osteoporotic fractures 
Source : Adopted from Lips 2001 
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1.5 VITAMIN D STATUS AND REQUIRED LEVEL OF VITAMIN D FOR  
     BONE HEALTH 
Vitamin D deficiency is now recognized as a global pandemic. A systematic review of 
vitamin D status in populations worldwide done in 2013 showed that 88.1% had mean 
vitamin D below 75 nmol/L, 37.3% had vitamin D level below 50 nmol/L and 6.7 % 
had values below 25 nmol/L (Hilger et al., 2014). These showed that there was big 
variability of the vitamin D status across the studies. No significant age or sex related 
differences in 25(OH)D values were observed in the sample worldwide but there is 
difference noted if compared by region (Hilger et al., 2014). Women tended to have 
lower vitamin D compared to men especially in the Asia and Middle East regions. 
 In Malaysia, a study done among adults in Kuala Lumpur revealed that approximately 
41% of male and 87% of females had insufficient (< 50 nmol/L) level of vitamin D 
(Moy and Bulgiba, 2011). Another study conducted among primary school children in 
Kuala Lumpur revealed that 35.3% having vitamin D deficiency (<37.5 nmol/L) and 
37.1 % having vitamin D insufficiency (37.5 - 50.0nmol/L) (Khor et al., 2011).  
Precisely defining vitamin D deficiency based on measurement of 25(OH)D 
concentration  is still a matter of much debate. There is no optimum level or threshold 
that has been clearly establish to define whether there is adequate store of vitamin D in 
the body or not (Thacher and Clarke, 2011). A wide optimum range for 25(OH) D has 
been reported based on various studies which is between 30 nmol/L until 90 nmol/L for 
bone health.  
Previous study showed a plateau in suppression of parathyroid hormone (PTH) when 
the 25(OH)D level reaches approximately 30 nmol/L which defines the optimum level 
(van Schoor and Lips, 2011). In addition, other study concluded that bone health in 
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older persons are likely to improve when serum 25(OH)D is raised over at least 50–60 
nmol/L (Kuchuk et al., 2009). There are also other studies by Vieth (2011) that 
mentioned, we should consider 25(OH)D value equal or more than 75nmol as an 
adequate or optimum level. The highest level of vitamin D for bone health is suggested 
by Krall (1989) which is up to 90 nmol/L. 
 
1.6 BONE TURNOVER MARKERS 
Bone is a metabolically active tissue that undergoes remodelling by two counteracting 
processes, which are bone formation and bone resorption. These processes depend on 
the activity of osteoblast (formation), osteoclast (resorption) and osteocyte 
(maintenance). These two processes are in balance under normal condition. The balance 
is regulated by various substances like vitamin D, parathyroid hormone and various 





Figure 1.3: The bone remodelling cycle. Under normal conditions, the resorption 
(osteoclast) phase takes approximately 10 days, which is then followed by a formation 
(osteoblast) phase that can last for up to 3 months. 
Source : Adopted from Seibel, 2005 
 
 If there is imbalance in these processes, it will lead to higher release of bone turnover 
markers, which are proteins originating from osteoclast and osteoblast activity or 
fragments released during the formation or degradation of type I collagen. In the event 
of vitamin D deficiency, there will be stimulation of secondary hyperparathyroidism 
due to hypocalcaemia. This hyperparathyroidism will caused negative balance in the 
bone metabolism by stimulating bone resorption and produces changes in bone 
structure, strength and mass. Changes in the bone structure and strength are difficult to 
measure in vivo and bone mass can be assessed by densitometric technique using dual 
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energy x-ray absorptiometry (DEXA) scan (Seibel, 2005). This scan produces a static 
measure and it can only detect clinical relevant changes of bone density after 2 years 
(Bonnick and Shulman, 2006). However the bone turnover markers  are helpful tools to 
detect the dynamics of the metabolic imbalance in the bone (Seibel et al., 2006). 
Markers like osteocalcin, N-terminal propeptide of type 1 collagen (P1NP) and bone 
specific alkaline phosphatase (BAP) are markers for bone formation  and markers for 
bone resorption includes hydroxyproline, hydroxylysine- glycoside and carboxyterminal 
crosslinked telopeptide of type 1 collagen (CTX).  
There were many studies showed that low serum 25(OH)D level are associated with an 
increased in bone turnover markers. Study done by Kuchuk et al ,2009 showed that 
parameters of bone turnover like osteocalcin and CTX were significantly lower in the 
higher vitamin D group. A study in German children also showed that increase in 
25(OH)D was associated with a significant decrease in the bone resorption marker, 






Figure 1.4 : Bone turnover markers 
BAP : bone alkaline phosphatase ; BSP: bone sialoprotein, TRAcP : tartrate-resistant 
acid phosphatase 










2. STUDY PROPOSAL 
2.1 INTRODUCTION 
Vitamin D, the sunshine vitamin, is a hormone which plays an important role in bone 
mineralisation and other metabolic processes in the body. This vitamin is important for 
optimum intestinal absorption of calcium and is a major physiologic reguIator of 
calcium absorption in the body. An altered plasma level of vitamin D is the most 
common mediator of increased or decreased calcium absorption in disease state. It is 
also needed for the release of calcium from bone in the regulation of plasma calcium 
and acts in concert with parathyroid hormone (PTH).  
Vitamin D deficiency is now recognized as a global pandemic. A systematic review of 
vitamin D status in populations worldwide done in 2013 showed that, among the Asian 
Pacific countries, Thailand had mean vitamin D level of 67.6 nmol/L, followed by 
Malaysia with 44.4 nmol/L and Indonesia with 38.7 nmol/L (Hilger et al,2014). This 
figure is based only on one study done by Rahman et al (2004) among postmenopausal 
women. A study by Nurbazlin et al (2013), showed that Malaysian women had mean 
vitamin D level of 64.5 nmol/L with the urban group had mean of 31.9 nmol/L and rural 
group of 69.5 nmol/l. This study also concentrates on vitamin D level among women 
who are> 45years old. There is no data on vitamin D status in general population as 
previous study is done among specific group e.g postmenopausal women, metabolic 
syndrome, primary school children, SLE patient. 
Vitamin D plays a crucial role in the development and maintenance of a healthy 
skeleton. It plays an important role in the calcium and phosphorus metabolism and helps 
to ensure adequate levels of these minerals for bone metabolism. Bone metabolism is 
comprised of two counteracting processes, namely bone formation and bone resorption. 
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Under normal condition, these two processes are tightly coupled to each other, so that 
the amount of bone resorbed is always equal to the amount of newly formed bone. This 
balance is achieved and regulated through the action of vitamin D, PTH and few others. 
In vitamin D deficiency, there will be imbalance between these two processes, thus will 
lead to bone mineral disease like osteoporosis, rickets and osteomalacia. 
Biochemical markers of bone turnover like osteocalcin (OC), N-terminal propeptide of 
type 1 collagen (P1NP) and bone specific alkaline phosphatase can reflect bone 
formation activity. For bone resorption, markers like hydroxyproline, 
hydroxylysineglycoside and carboxyterminal crosslinked telopeptide of type 1 collagen 
(CTX) are used to assess bone resorption activity. There were studies showed that low 
serum 25(OH)D level are associated with an increased bone turnover.A study done by 
Natalia et al (2009) showed that serum osteocalcin (bone formation) and serum CTX 
(bone resorption), were significantly lower in the highest serum 25(OH)D group. 
Our study is different from other studies as we use bone turnover markers (BTMs) 
instead of bone mineral density (BMD) measured by DEXA scan to estimate the 
optimum level of vitamin D. The BTM usage has been encouraged in clinical practice 
and clinical applications because of its usefulness. BTMs reflect the remodelling 
process of the bone but the BMD does not. The BTM will change earlier and in larger 
extent after starting of treatment in osteoporosis compared to changes in BMD (Yoshiki 
et al, 2004). It has been reported that a decrease in BTM in the early stage of treatment 
in osteoporosis may reflect a reduction in the long term risk of fracture (Eastell et al, 
2003). 
Until now, there is still no standard definition of optimal vitamin D status. The required 
serum 25(OH)D for adequate bone health has been debated. The optimum level of 
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serum 25(OH)D was estimated according to some studies to be at 30,50,70,75 and 80 
nmol/L. Therefore, the aim of our study is to estimate the threshold of serum 25(OH)D 
with regard to PTH and bone turnover markers in a population of Kota Bharu, Kelantan. 
The reason why we choose to have this study done here is because Kota Bharu can 
represent both the urban and also the suburban population in Kelantan.  Its population 
also has a heterogeneous background from government servants, odd job workers and 
etc. 
 
2.2 JUSTIFICATION OF THE STUDY 
There were very limited studies and published data on vitamin D status among general 
adult population in Malaysia. Most of the studies were done among specific group like 
postmenopausal women, metabolic syndrome, primary school children and among 
patient with diseases like SLE. 
Study on optimum level of vitamin D that is needed for bone health is done mostly in 
Western countries only. The results of the studies showed that the optimum level of 
vitamin D varied between 30- 100 nmol/L. There is not much data about this in our 
Asian (Malaysian) population. We are expecting that the value would be different 







2.3 BENEFITS FROM THE STUDY 
1. The result of this study can be used as a guide to determine the optimum level of 
vitamin D for maintaining good bone health in our own population. 
2. The result from this study also can be a guide to the clinician at optimizing vitamin D 
level in patient who is vitamin D deficient and are at high risk to develop osteoporosis 
and fractures. 
2.4  OBJECTIVES 
General Objective 
 To study on vitamin D status and its association with PTH and bone turnover 
markers 
Specific Objectives 
1. To determine the mean vitamin D level among Kota Bharu population 
2. To determine the relationship of vitamin D level with PTH and serum bone turnover  
    markers ,N-terminal propeptide of type 1 collagen (P1NP) and C- telopeptide(CTX). 
3. To determine the threshold of optimum vitamin D level with regard to PTH and  
    serum bone turnover markers, N-terminal propeptide of type 1 collagen (P1NP) and    






2.5 RESEARCH QUESTIONS 
1. What is the vitamin D status among Kota Bharu population? 
2. Is there any relationship between vitamin D level with PTH and bone turnover  
    markers, N-terminal propeptide of type 1 collagen (P1NP) and C- telopeptide(CTX)? 
3. What is the optimum level of vitamin D for good bone health? 
 
2.6 HYPOTHESIS 
1. There is good relationship between vitamin D level with PTH and bone turnover 
markers, N-terminal propeptide of type 1 collagen (P1NP) and C- telopeptide(CTX) 
 
2.7  METHODOLOGY: 
Study design 
Cross sectional study 
Study duration 
1 February 2015 till 31 January 2017 
Study location 
Kota Bharu, Kelantan 
Reference population 




Residents in 6 subdistricts aged 18-50 years old 
Sampling frame 
Selected village of 6 subdistricts in Kota Bharu 
Sampling methods 
120 people will be chosen using multistage sampling. For the first stage, six out of 14 
subdistricts in Kota Bharu will be selected. Secondly, a village from each 6 subdistricts 
will be randomly selected and later, all residents in the selected village who aged 
between 18-50 years old and fulfil the inclusion and exclusion criteria will be randomly 
chosen and offered to participate in the study. 
They were given the information sheet and consent form. They should read and sign it 
before taking part in this study. 5 mls of blood then will be taken from each subject and 
put into bottle. It will then be analyzed for vitamin D, intact PTH, and bone turnover 
markers like P1NP and C- telopeptide(CTX). 
Inclusion criteria 
 Aged 18-50 years 
Exclusion criteria 
 People with established bone mineral disease e.g osteoporosis 
 People on drugs that affect vitamin D and bone turnover; OCP,HRT, steroid 
 People with history of severe chronic liver disease, diabetes mellitus type 1 and 
2, chronic kidney disease stage 3 and thyroid disorders 
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 Those female who are pregnant and breastfeeding 
 Those female who had menopause 
 Those who take alcohol 
 Those who had history of recent fracture (up to 1 year) 
 Those who are on vitamin D supplement 
 
2.8 SAMPLE SIZE DETERMINATION 
Based on objective no.1, 
Calculation done using single mean formula. Data taken from Moy and Bulgiba (2011), 
High prevalence of vitamin D deficiency. 
n = [(z (SD))/Δ]^2 
   = [(1.96(13))/4] 
   = 40 
 
Based on objective no.2, 
Calculation done using G power software 3.1.7 with effect size of 0.10 (small, Cohen, 
1988) 
α , probability of Type I error = 0.05, power (1β) = 0.8 
Expected number of predictors = 2 
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Total sample size needed is 100 
# So, the biggest number of sample size is 100 
Sample size, n = 100 + 20 % drop out = 100 + 20 workers 
                        = 120 
 
2.9 MEASUREMENT TOOLS / LABORATORY METHODS 
Estimation of serum vitamin D, intact PTH and bone turnover markers (osteocalcin, 
P1NP and CTX) will be done by immunoassay technique using COBAS e 411. 
 
2.10 STATISTICAL ANALYSIS 
The data will be analyzed by using computer software SPSS version 20. 
For objective 1, the numerical data will be expressed as mean (SD). 
For objective 2, simple linear regression analysis will be performed to examine the 
correlation between vitamin D level with bone turnover markers. 
For objective 3, LOESS plot will be performed by using Stata software. The optimum 







3.0  MANUSCRIPT 
STUDY ON VITAMIN D STATUS AND DETERMINATION OF OPTIMUM    
VITAMIN D LEVEL BASED ON BONE TURNOVER MARKERS IN KOTA     
BHARU, KELANTAN                   
      
3.1 Abstract 
Background: There is no optimum level or threshold that has been clearly established 
to define whether there is adequate store of 25(OH)D in the body for general bone 
health. Therefore, our study was to determine the optimum level of 25(OH)D for 
maintenance of healthy skeleton based on bone remodelling process among healthy 
adult in Kota Bharu. 
Methods: This was a cross sectional study involving healthy adult population in Kota 
Bharu, Malaysia, aged 18-50 years. We measured serum 25(OH)D, serum parathyroid 
hormone (PTH), serum C-terminal telopeptide of type 1 collagen (CTX) and  
Procollagen 1 Intact N-Terminal (P1NP) in 120 healthy adult from 6 sub districts that 
had been selected by multi stage sampling ( 64 males, 56 females). 
Results: The mean level of 25(OH)D in this study was 23.50 (± 8.74) nmol/L and there 
was significant difference of vitamin D between gender (26.81±8.3nmol/L and 
19.72±7.68 nmol/L males and females respectively) ( p value < 0.001). More than 50% 
of female subjects had 25(OH)D less than 20nmol/L, while only 20.3% of male subjects 
had 25(OH)D below 20nmol/L. Based on LOESS plot, the bone turnover markers 
showed plateau result at 25(OH)D level of 35 nmol/L for  CTX and 20 nmol/L for 
P1NP. Then, at 25(OH)D level of 20 nmol/L there is a step decrease of PTH level. 
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Conclusion: The mean level of 25(OH)D among general healthy population in Kota 
Bharu was 23.50nmol/L. Based on LOESS plot for CTX, P1NP and PTH versus 
vitamin D level, we concluded that vitamin D level between 20 nmol/L to 35 nmol/L is 
considered sufficient to maintain healthy skeleton. 
 
Keywords: Vitamin D; Bone turnover markers; N-terminal propeptide of type 1 
collagen (P1NP); C- telopeptide(CTX);  Parathyroid hormones(PTH) 
 
3.2 Introduction 
Vitamin D plays a pivotal role in the development and maintenance of a healthy 
skeleton. It plays a critical function in the calcium and phosphorus metabolism and 
helps ensure adequate levels of these minerals for bone mineralization [1]. In adults, 
low vitamin D can results in osteomalacia which is a defective mineralization of the 
collagen matrix causing a reduction of structural support and being associated with an 
increased risk of fracture [2]. 
A low prevalence of vitamin D is expected in tropical countries which received 
abundant of sun exposure because the most important source of vitamin D is by 
cutaneous synthesis under the action of sunlight. The sunlight convert 7-
dehydrocholesterol in the skin to vitamin D3, which will be transported to the liver and 
hydroxylated to 25-hydroxyvitamin D [(25-OH)D]. It will then be conveyed to the 
kidney and hydroxylated to 1,25-dihydroxyvitamin D[1,25(OH)2D]. The primary 
circulating form of vitamin D is 25(OH)D and it has longer half life (2-3 weeks) 
compares to 4-6 hours for 1,25(OH)2D, thus accepted as the determinant of vitamin D 
24 
 
status [3]. Having said that , the prevalence of vitamin D deficiency in countries like 
Hawaii, Iran, India, and Saudi Arabia which received sunlight throughout the year are 
high [4, 5, 6, 7].    
Vitamin D deficiency is now recognized as a global pandemic. A systematic review of 
vitamin D status in populations worldwide done in 2013 showed that 37.3% of the 
sample had vitamin D level below 50 nmol/L and 6.7 % had values below 25 nmol/L 
[8]. In Malaysia, a study done among adults in Kuala Lumpur revealed that 
approximately 41% of male and 87% of females had insufficient (< 50 nmol/L) level of 
vitamin D [9]. Another study conducted among primary school children in Kuala 
Lumpur revealed that 35.3% having vitamin D deficiency (<37.5 nmol/L) and 37.1 % 
having vitamin D insufficiency (37.5 - 50.0nmol/L) [10]. Despite mounting evidence of 
vitamin D status globally, there are still lack of studies in our local setting, determining 
the level of vitamin D especially among general population.  
Precisely defining vitamin D deficiency based on measurement of 25(OH)D 
concentration  is still a matter of much debate. There is no optimum level or threshold 
that has been clearly established to define whether there is adequate store of vitamin D 
in the body or not [11]. Previous study showed a plateau in suppression of parathyroid 
hormone (PTH) when the 25(OH)D level reaches approximately 30 nmol/L which 
defines the optimum level [12]. In addition, other study concluded that bone health in 
older persons are likely to improve when serum 25(OH)D is raised over at least 50–60 
nmol/L [13]. There are also other studies in which the researcher consider 25(OH)D 
value equal or more than 75nmol as an adequate or optimum level [14]. Therefore, this 
study aims to determine the optimum level of vitamin D based on bone remodelling 
process. 
